Canada Research Roundup: Enbridge, Gildan Activewear, Rogers Sugar

Cardiol Therapeutics

24/03/2020 08:27

March 24 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Enbridge, Gildan Activewear and Rogers Sugar, on Tuesday. 
    
  HIGHLIGHTS
     * Enbridge Inc  ENB.TO : Jefferies raises to buy from hold
     * Gildan Activewear  GIL.TO : National Bank of Canada cuts target price to C$23 from C$42
     * Rogers Sugar  RSI.TO : National Bank of Canada cuts target price to C$3.75 from C$4.50
 
Following is a summary of research actions on Canadian companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
     
     * Cardiol Therapeutics  CRDL.TO : Altacorp Capital cuts target price to C$8.15 from C$9
     * Chemtrade Logistics Income Fund  CHE_u.TO : National Bank of Canada cuts TP to C$7 from C$11
     * Enbridge Inc  ENB.TO : Jefferies raises to buy from hold
     * Ensign Energy Services  ESI.TO : Altacorp Capital cuts target price to C$0.60 from C$1
     * Gildan Activewear  GIL.TO : National Bank of Canada cuts target price to C$23 from C$42
     * Melcor REIT  MR_u.TO : CIBC cuts target price to C$6 from C$8
     * Nfi Group Inc  NFI.TO : Altacorp Capital cuts target price to C$30 from C$35
     * Nfi Group Inc  NFI.TO : CIBC cuts target price to C$26 from C$35
     * Orla Mining  OLA.TO : Scotiabank raises price target to C$2.75; rating sector perform
     * Parkland Fuel Corp  PKI.TO : RBC cuts target price to C$35 from C$46
     * Rogers Sugar  RSI.TO : National Bank of Canada cuts target price to C$3.75 from C$4.50
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))